D. Manning and N. Afdhal, Diagnosis and Quantitation of Fibrosis, Gastroenterology, vol.134, issue.6, pp.70-81, 2008.
DOI : 10.1053/j.gastro.2008.03.001

L. Castera, J. Denis, G. Babany, and F. Roudot-thoraval, Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?, Journal of Hepatology, vol.46, issue.3, pp.528-537, 2007.
DOI : 10.1016/j.jhep.2006.12.002

H. Fontaine, K. Petitprez, F. Roudot-thoraval, and J. Trinchet, Guidelines for the diagnosis of uncomplicated cirrhosis, Gastroent??rologie Clinique et Biologique, vol.31, issue.5, pp.504-513, 2007.
DOI : 10.1016/S0399-8320(07)89420-6

P. Halfon, M. Munteanu, and T. Poynard, FibroTest-ActiTest as a non-invasive marker of liver fibrosis, Gastroent??rologie Clinique et Biologique, vol.32, issue.6, pp.22-38, 2008.
DOI : 10.1016/S0399-8320(08)73991-5

P. Bedossa, D. Dargère, and V. Paradis, Sampling variability of liver fibrosis in chronic hepatitis C, Hepatology, vol.36, issue.6, pp.1449-1457, 2003.
DOI : 10.1016/j.hep.2003.09.022

V. Ratziu, C. F. Heurtier, A. Gombert, S. Giral, P. Bruckert et al., Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.128, issue.7, pp.1898-1906, 2005.
DOI : 10.1053/j.gastro.2005.03.084

T. Poynard, M. Munteanu, F. Imbert-bismut, C. F. Thabut, D. et al., Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C, Clinical Chemistry, vol.50, issue.8, pp.1344-1355, 2004.
DOI : 10.1373/clinchem.2004.032227

T. Poynard, M. Muntenau, R. Morra, Y. Ngo, F. Imbert-bismut et al., Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update, Gastroent??rologie Clinique et Biologique, vol.32, issue.6, pp.8-21, 2008.
DOI : 10.1016/S0399-8320(08)73990-3

T. Poynard, P. Ingiliz, L. Elkrief, M. Munteanu, P. Lebray et al., Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers, PLoS ONE, vol.55, issue.12, p.3857, 2008.
DOI : 10.1371/journal.pone.0003857.s012

P. Halfon, F. Imbert-bismut, D. Messous, G. Antoniotti, D. Benchetrit et al., A prospective assessment of the interlaboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease, Comparative Hepatology, vol.2, pp.3-7, 2002.

F. Imbert-bismut, D. Messous, V. Thibaut, R. Myers, A. Piton et al., Intralaboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors, Clin Chem Lab Med, vol.42, pp.323-333, 2004.

G. Ferard, F. Imbert-bismut, D. Messous, A. Piton, S. Ueda et al., A reference material for traceability of aspartate aminotransferase (AST) results, Clinical Chemical Laboratory Medicine, vol.43, issue.5, pp.549-53, 2005.
DOI : 10.1515/CCLM.2005.095
URL : https://hal.archives-ouvertes.fr/hal-00129859

G. Ferard, A. Piton, D. Messous, F. Imbert-bismut, A. Frairi et al., Intermethod calibration of alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) results: application to Fibrotest and Actitest scores, Clin Chem Lab Med, vol.44, pp.400-406, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00129861

F. Imbert-bismut, D. Messous, A. Raoult, T. Poynard, J. Bertrand et al., BN2 (Dade Behring) and modular DP (Roche Diagnostics) analysers: application to component assays of fibrotest and Actitest, Ann Biol Clin, vol.63, pp.305-318, 2005.

A. Piton, D. Messous, F. Imbert-bismut, J. Berges, M. Munteanu et al., Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra) Application to FibroTest-ActiTest, Ann Biol Clin, vol.63, pp.385-95, 2005.

F. Imbert-bismut, V. Ratziu, L. Pieroni, C. F. Benhamou, Y. Poynard et al., Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, The Lancet, vol.357, issue.9262, pp.1069-75, 2001.
DOI : 10.1016/S0140-6736(00)04258-6

R. Myers, M. Tainturier, V. Ratziu, A. Piton, V. Thibault et al., Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B, Journal of Hepatology, vol.39, issue.2, pp.222-252, 2003.
DOI : 10.1016/S0168-8278(03)00171-5

S. Naveau, B. Raynard, V. Ratziu, A. Abella, F. Imbert-bismut et al., Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease, Clinical Gastroenterology and Hepatology, vol.3, issue.2, pp.167-74, 2005.
DOI : 10.1016/S1542-3565(04)00625-1

V. Ratziu, J. Massard, C. F. Messous, D. Imbert-bismut, F. Bonyhay et al., Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease, BMC Gastroenterology, vol.277, issue.1, p.6, 2006.
DOI : 10.1074/jbc.M107771200

T. Poynard, R. Morra, P. Halfon, L. Castera, V. Ratziu et al., Meta-analyses of FibroTest diagnostic value in chronic liver disease, Meta-analyses of Fibrotest diagnostic value in chronic liver disease, p.40, 2007.
DOI : 10.1016/j.jhep.2006.12.002

P. Bedossa, T. Poynard, and . Metavir, An algorithm for the grading of activity in chronic hepatitis C, Hepatology, vol.24, issue.2, pp.289-93, 1996.
DOI : 10.1002/hep.510240201

T. Poynard, P. Lebray, P. Ingiliz, A. Varaud, B. Varsat et al., Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest), BMC Gastroenterology, vol.360, issue.324, p.40, 2010.
DOI : 10.1056/NEJMoa0810084

P. Halfon, F. Carrat, P. Bédossa, J. Lambert, G. Penaranda et al., Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study -ANRS HC02, Antivir Ther, vol.14, pp.211-220, 2009.

A. Allison, B. Blumberg, and R. W. , Haptoglobin Types in British, Spanish Basque and Nigerian African Populations, Nature, vol.20, issue.4612, p.824, 1958.
DOI : 10.1002/ajpa.1330070405

J. Hintze, NCSS 2007 User Guide. Number Cruncher Statistical Systems software NCSS, 2007.

L. Castera, J. Foucher, P. Bernard, F. Carvalho, D. Allaix et al., Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations, Hepatology, vol.46, pp.828-863, 2010.
DOI : 10.1002/hep.23425

M. Diop, J. Bastard, N. Meunier, S. Thevenet, M. Maachi et al., Inappropriately Low Glycated Hemoglobin Values and Hemolysis in HIV-Infected Patients, AIDS Research and Human Retroviruses, vol.22, issue.12, pp.1242-1249, 2006.
DOI : 10.1089/aid.2006.22.1242
URL : https://hal.archives-ouvertes.fr/inserm-00848103

P. Cacoub, F. Carrat, P. Bedossa, J. Lambert, G. Penaranda et al., Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study ??? ANRS HC02, Journal of Hepatology, vol.48, issue.5, pp.765-73, 2008.
DOI : 10.1016/j.jhep.2008.01.025

J. Bottero, K. Lacombe, J. Guechot, L. Serfaty, P. Miailhes et al., Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients, Journal of Hepatology, vol.50, issue.6, pp.1074-83, 2009.
DOI : 10.1016/j.jhep.2009.01.022

P. Bonnard, R. Sombié, F. Lescure, A. Bougouma, J. Guiard-schmid et al., Comparison of Elastography, Serum Marker Scores, and Histology for the Assessment of Liver Fibrosis in Hepatitis B Virus (HBV)-Infected Patients in Burkina Faso, American Journal of Tropical Medicine and Hygiene, vol.82, issue.3, pp.454-462, 2010.
DOI : 10.4269/ajtmh.2010.09-0088

K. Schloter and D. Drenckhahn, Co-clustering of denatured hemoglobin with band 3: its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes., Proceedings of the National Academy of Sciences, vol.83, issue.16, pp.6137-6178, 1986.
DOI : 10.1073/pnas.83.16.6137

D. Sène, N. Limal, D. Messous, P. Ghillani-dalbin, C. F. Halfon et al., Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis, Clinical Biochemistry, vol.39, issue.7, pp.715-736, 2006.
DOI : 10.1016/j.clinbiochem.2006.04.019

M. Munteanu, D. Messous, D. Thabut, F. Imbert-bismut, M. Jouys et al., Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest), Comparative Hepatology, vol.3, issue.1, p.3, 2004.
DOI : 10.1186/1476-5926-3-3

K. Mazodier, V. Marin, D. Novick, C. Farnarier, S. Robitail et al., Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome, Blood, vol.106, issue.10, pp.153483-153492, 2005.
DOI : 10.1182/blood-2005-05-1980

J. Lamarre, B. Wolf, E. Kittler, P. Quesenberry, and S. Gonias, Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma., Journal of Clinical Investigation, vol.91, issue.3, pp.1219-1243, 1993.
DOI : 10.1172/JCI116283

L. Castera and M. Pinzani, Non-invasive assessment of liver fibrosis: are we ready?, The Lancet, vol.375, issue.9724, pp.1419-1439, 2010.
DOI : 10.1016/S0140-6736(09)62195-4